While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.
A business making money today isn’t necessarily a winner, which is why we analyze companies across multiple dimensions at StockStory. That said, here is one profitable company that balances growth and profitability and two that may struggle to keep up.
Two stocks to sell:
The Pennant Group (PNTG)
Trailing 12-Month GAAP Operating Margin: 5.7%
Spun off from The Ensign Group in 2019 to focus on non-skilled nursing healthcare services, Pennant Group (NASDAQ: PNTG) operates home health, hospice, and senior living facilities across 13 western and midwestern states, serving patients of all ages including seniors.
Why Are We Cautious About PNTG?
- Modest revenue base of $1.09 billion gives it less fixed cost leverage and fewer distribution channels than larger companies
- Low free cash flow margin of 2.4% for the last five years gives it little breathing room, constraining its ability to self-fund growth or return capital to shareholders
- High net-debt-to-EBITDA ratio of 6× increases the risk of forced asset sales or dilutive financing if operational performance weakens
The Pennant Group’s stock price of $41.66 implies a valuation ratio of 28.5x forward P/E. Dive into our free research report to see why there are better opportunities than PNTG.
Bunge Global (BG)
Trailing 12-Month GAAP Operating Margin: 2.3%
With origins dating back to 1818 and operations spanning both hemispheres to balance seasonal harvests, Bunge Global (NYSE: BG) is an agribusiness and food company that processes oilseeds, grains, and other agricultural commodities into vegetable oils, protein meals, flours, and specialty ingredients.
Why Are We Wary of BG?
- Sales are projected to remain flat over the next 12 months as demand decelerates from its three-year trend
- Gross margin of 5.4% is an output of its commoditized products
- Performance over the past three years shows its incremental sales were much less profitable, as its earnings per share fell by 16% annually
Bunge Global is trading at $103 per share, or 9.9x forward P/E. Check out our free in-depth research report to learn more about why BG doesn’t pass our bar.
One stock to buy:
Bloom Energy (BE)
Trailing 12-Month GAAP Operating Margin: 14.8%
Working in stealth mode for eight years, Bloom Energy (NYSE: BE) designs, manufactures, and markets solid oxide fuel cell systems for on-site power generation.
Why Will BE Beat the Market?
- Impressive 74.5% annual revenue growth over the last two years indicates it’s winning market share this cycle
- Free cash flow turned positive over the last five years, indicating the company has achieved financial self-sustainability
- Historical investments are beginning to pay off as its returns on capital are growing
At $192.61 per share, Bloom Energy trades at 45x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
Stocks we like even more
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.
